Actively Recruiting
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers
Led by Il-Yang Pharm. Co., Ltd. · Updated on 2026-03-27
86
Participants Needed
1
Research Sites
62 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A randomized, double-blinded, partial-open, placebo/active-controlled, single/multiple dosing, dose escalation phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of IY-828026 in healthy adult volunteers
CONDITIONS
Official Title
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy adult volunteers aged 69 and 64 50 years at screening
- Body weight 69 50.0 kg to 64 90.0 kg and body mass index (BMI) of 69 18.5 kg/m2 to 64 29.9 kg/m2 at screening
- Volunteers who fully understood the study, agreed voluntarily, and provided written consent to follow precautions
You will not qualify if you...
- Current or history of significant disease involving liver, kidneys, nervous, immune, lungs, stomach/intestines, hormone, blood, heart, urinary, psychiatric system, or sexual dysfunction
- H. pylori treatment within 6 months or positive H. pylori test at screening
- Allergic or significant hypersensitivity to PPIs, P-CABs, aspirin, antibiotics, or related drugs
- Positive tests for hepatitis B, hepatitis C, HIV, or syphilis
- History or positive test for drug abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea
Actively Recruiting
Research Team
Y
YunSeon Kim
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
10
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here